Methodological issues raised by clinical trials on dysthymia: Assessment instruments and response criteria

European Psychiatry

Volumn 12, Issue 4, 1997, Pages 183-189

  Guelfi, J D ^a   Corruble, E ^a  

^a HÔPITAL PAUL BROUSSE   (France)

Author keywords

Assessment tools; Clinical trials; Diagnostic criteria; Dysthymia

Indexed keywords

ANTIDEPRESSANT AGENT; FLUOXETINE; IMIPRAMINE; MOCLOBEMIDE; PHENELZINE; RITANSERIN;

CONFERENCE PAPER; DISEASE COURSE; DISEASE SEVERITY; DRUG RESPONSE; DYSTHYMIA; HUMAN; METHODOLOGY; PERSONALITY; PRIORITY JOURNAL; SYMPTOMATOLOGY;

EID: 0030987439     PISSN: 09249338     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-9338(97)89102-X     Document Type: Conference Paper

References (61)

1. Akiskal HS. Clinical subtypes of chronic-resistant depression. In: Feighner JP, Boyer WF, eds. The diagnosis of depression. New York: J Wiley and Sons Ltd, 1991;150-62
2. APA. Diagnostic and Statistical Manual of Mental Disorders, Second Edition. Washington DC: American Psychiatric Association, 1968
3. APA. Diagnostic and Statistical Manual of Mental Disorders, Third Edition. Washington DC: American Psychiatric Association, 1980
4. APA. Diagnostic and Statistical Manual of Mental Disorders, Revised Third Edition. Washington DC: American Psychiatric Association, 1987
5. APA. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington DC: American Psychiatric Association, 1994
6. Andrews G, Singh M, Bond M. The defense style questionnaire. J Nerv Ment Dis 1993;181:246-56
7. Angst J, Wicki W. The Zürich Study: Is dysthymia a separate form of depression? Results of the Zürich cohort study. Eur Arch Psychiatry Clin Neurosci 1991;240:349-54
8. Bakish D, Lapierre YD, Weinstein R et al. Ritanserine, imipramine and placebo in the treatment of dysthymic disorder. J Clin Psychopharmacol 1993;13:409-14
9. Beck AT. Depression Inventory. Philadelphia: Center for Cognitive Therapy, 1978
10. Bloch AL, Shear MK, Markowitz JC et al. An empirical study of defense mechanisms in dysthymia. Am J Psychiatry 1993;150:1194-8
11. Bond M, Perry JC, Gautier M et al. Validating self-report of defense styles. J Pers Disord 1989;3:101-12
12. de Jong R, Treiber R, Henrich G. Effectiveness of two psychological treatments for inpatients with severe and chronic depressions. Cognitive Ther Res 1986;10:645-63
13. Derogatis LR, Lipman RS, Rickels K et al. The Hopkins Symptom Check List (HSCL): a self-report symptom inventory. Behav Sci 1974;19:1-15
14. Derogatis LR. SCL-90R (revised) version Manual 1. Baltimore: Clinical Psychometrics Research Unit, John Hopkins University School of Medicine, 1977
15. Frances A. Recurrent brief depression, dysthymia and melancholia. Int Clin Psychopharmacol 1993;7:197-200
16. Frances A, Kocsis J, Marin D et al. Diagnosis criteria for dysthymic disorder. Psychopharmacol Bull 1989;25:325-9
17. Frank E, Prien RF, Jarett RB et al. Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Arch Gen Psychiatry, 1991;48:851-5
18. Guelfi JD, Pichot P, Dreyfus JF. Efficacy of tianeptine in anxious-depressed patients: results of a controlled multicenter trial versus amitriptyline. Neuropsychobiology 1989;22:41-8
19. Guelfi JD. Clinical research in psychopharmacology: new standards for drug development. An application to antidepressants. Psychiatr Psychobiol 1990;5:289-94
20. Guelfi JD. L'échelle de dépression de Hamilton. In: L'évaluation clinique standardisée en Psychiatrie, Tome 1. Guelfi JD, ed. Boulogne: Editions Médicales Pierre Fabre, 1993
21. Gwirtsman HE. Overview of the diagnosis, prevalence and comorbidity of dysthymia. Psychopharmacol Bull 1994; 30:45-51
22. Harpin RE, Liberman RP, Marks I, Stern R, Bohannon WE. Cognitive behavior therapy for chronically depressed patients: a controlled pilot study. J Nerv Ment Dis 1982; 170:295-301
23. Hellerstein DJ, Yanowitch P, Rosenthal J et al. A randomized double-blind study of fluoxetine versus placebo in the treatment of dysthymia. Am J Psychiatry 1993;150:1169-75
24. Hirschfeld RMA, Holzer CE. Depressive personality disorder: clinical implications. J Clin Psychiatry 1994;55:S10-17
25. Keller MB. Course, outcome and impact on the community. Acta Psychiatry Scand 1994;89:S24-34
26. Keller MB, Lavori PW. Double depression, major depression and dysthymia: distinct entities or different phases of a single disorder? Psychopharmacol Bull 1984;20:399-402
27. Keller M.B., Shapiro R.W. "Double depression": superimposition of acute depressive episodes on chronic depressive disorders. Am. J. Psychiatry, 1982;139:438-42
28. Keller MB, Klein DN, Hirschfeld RMA et al. Results of the DSM-IV Mood Disorders Field Trial. Am J Psychiatr 1995;152:843-9
29. Klein DN. Depressive personality: reliability, validity and relation to dysthymia. J Abn Psychol 1990;99:412-21
30. Klerman GL, Weissman MM, Frank E et al. Evaluating drug treatments of depressive disorders. In: Prien RF, Robinson DS, eds. Clinical Evaluation of Psychotropic Drugs: Principles and Guidelines. New York: Raven Press Ltd, 1994;281-325
31. Kocsis JH, Frances AJ. A critical discussion of DSM-III dysthymic disorder. Am J Psychiatry 1987;144:1534-42
32. Kocsis JH, Frances AJ, Voss C et al. Imipramine treatment for chronic depression. Arch Gen Psychiatry 1988;45:253-7
33. Kocsis JH, Thase ME, Koran L et al. Pharmacotherapy for "pure" dysthymia: sertraline versus imipramine and placebo. Eur Neuropsychopharmacol 1994;4:S204
34. Lapierre YD. Pharmacological therapy of dysthymia. Acta Psychiatr Scand 1994;89:S42-8
35. Lecrubier Y. Pharmacological interventions in dysthymia. Eur Psychiatry 1996;11(Suppl 3):129s-33s
36. Lopez Ibor JJ, Frances A, Jones C. Dysthymic disorder: a comparison of DSM-IV and ICD-10 and issues in differential diagnosis. Acta Psychiatr Scand 1994;89:S12-18
37. MacCullough JP. Psychotherapy for dysthymia: a naturalistic study of ten patients. J Nerv Ment Dis 1991;179:734-40
38. MacCullough JP, MacCune KJ, Kaye AL et al. Comparison of a community dysthymia sample at screening with a matched group of nondepressed community controls. J Nerv Ment Dis 1994;182:402-7
39. Marin DB, Kocsis JH, France AJ, Parides M. Desipramine for the treatment of "pure" dysthymia versus "double" depression. Am J Psychiatry 1994;151:1079-80
40. Markowitz JC. Psychotherapy of dysthymia. Am J Psychiatry 1994;151:1114-21
41. Mason BJ, Markowitz JC, Klerman GL. Interpersonal psychotherapy for dysthymic disorders. In: Klerman GL, Weissman MM, eds. New Applications of Interpersonal Therapy. Washington: American Psychiatric Press, 1993
42. Mercier MA, Stewart JW, Quitkin FM. A pilot sequential study of cognitive therapy and pharmacotherapy of atypical depression. J Clin Psychiatry 1992;53:166-70
43. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979;134:382-9
44. Osser DN. A systematic approach to the classification and pharmacotherapy of nonpsychotic major depression and dysthymia. J Clin Psychopharmacol 1993;13:133-44
45. Pepper CM, Klein DN, Anderson RL et al. DSM-III-R axis II comorbidity in dysthymia and major depression. Am J Psychiatry 1995;152:239-47
46. Perry JC, Cooper SH. An empirical study of defense mechanisms. Arch Gen Psychiatry 1989;46:444-52
47. Rotter JB. Generalized Expectancies for Internal versus External Control of Reinforcement. Psychological Monographs N° 609, 1966
48. Rush AJ, Giles DE, Schlesser MA et al. The Inventory for Depressive Symptomatology: Preliminary findings. Psychiatr Res 1985;18:65-7
49. Sanderson WC, Wetler S, Beck AT, Betz F. Prevalence of personality disorders in patients with major depression and dysthymia. Psychiatr Res 1992;42:93-9
50. Stewart JH, MacGrath PJ, Liebowitz MR et al. Treatment outcome validation of DSM-III depressive subtypes. Arch Gen Psychiatry 1985;42:1148-53
51. Stewart JW, Quitkin FM, McGrath PJ et al. Social functioning in chronic depression: effects of 6 weeks of antidepressant treatment. Psychiatry Res 1988;25:213-22
52. Stravynski A, Shahar JW, Quitkin FM. A pilot study of the cognitive treatment of dysthymic disorder. Behavioural Psychotherapy 1991;4:369-72
53. Tyrer P, Seivewright N, Ferguson B et al. The Nottingham Study of neurotic disorder. Br J Psychiatry 1993;162: 219-26
54. Vallejo J, Gasto C, Catalan R, Salamero M. Double-blind study of imipramine versus phenelzine in melancholias and dysthymic disorders. Br J Psychiatry 1987;151:639-42
55. Versiani M, Nardi E, Capponi R. Moclobemide compared with imipramine in the treatment of chronic depression (dysthymia DSM-III-R): a double-blind placebo controlled trial. Clin Neuropharmacol 1992;15:148-9
56. Waintraub L, Guelfi JD. The validity of the concept of dysthymia. Eur Psychiatry, in press
57. Weissman MM, Prusoff BA, Thomson WD et al. Social adjustements by self-report in a community sample and in psychiatric outpatients. J Nerv Ment Dis 1978;166:317-26
58. Weissman MM, Leaf PJ, Bruce ML, Florio L. The epidemiology of dysthymia in five communities: rates, risks, comorbidity and treatment. Am J Psychiatry 1988;145:815-19
59. World Health Organization. Mental Disorders: Nineth revision of the International Classification of Diseases. Geneva: WHO, 1978
60. World Health Organization. Mental Disorders: Tenth revision of the International Classification of Diseases. Geneva: WHO, 1992
61. Zung WWK. A self-rating depression scale. Arch Gen Psychiatry 1965;12:63